Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical...
Transcript of Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical...
![Page 1: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/1.jpg)
Tumor Immunotherapy
Slides kindly provide by Prof. Chatchai Tayapiwatana, CMU
![Page 2: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/2.jpg)
RituximabAnti-CD20
2
![Page 3: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/3.jpg)
GENERACIÓ DE LA VACUNA
Extracció d’una mostra de sang per a l’obtenció de DCs
Aïllament dels monòcits i diferenciació ex vivo a DCs
Virus autòlegs obtinguts per plasmafèresis
Pulsing dels virus i les DCs aulòlegs
Obtenció de la vacuna terapèutica
Dendritic cells
Autologous virus Inactivation
Lymphopheresis Culture
Autologous vaccine
GENERACIÓ DE LA VACUNA
Extracció d’una mostra de sang per a l’obtenció
de DCs
Aïllament dels monòcits i diferenciació ex vivo a DCs
Virus autòlegs obtinguts per plasmafèresis
Pulsing dels virus i les DCs aulòlegs
Obtenció de la vacuna terapèutica
Monocytes
Immunization
Inactivated virus
?
![Page 4: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/4.jpg)
Development of Tumor Vaccines
![Page 5: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/5.jpg)
Types of Tumor Vaccines
![Page 6: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/6.jpg)
Strategies for enhancing immune responses to tumors
![Page 7: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/7.jpg)
Immunotherapy w/ Cytokine Gene-Transfected Tumor Cells
![Page 8: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/8.jpg)
Systemic Cytokine Therapy for Tumors
![Page 9: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/9.jpg)
Adoptive Cellular Therapy
Ex vivo activate CTLs or NK cells
![Page 10: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/10.jpg)
10
![Page 11: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/11.jpg)
11
![Page 12: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/12.jpg)
CAR-T-cell Immunotherapy
Chimeric antigen receptor
![Page 13: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/13.jpg)
13
![Page 14: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/14.jpg)
14
![Page 15: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/15.jpg)
Chimeric antigenreceptors(CARs)
oCARs areengineeredreceptorsonimmuneeffectcell.
15
http://www.discoverymedicine.com/Michael-S-gee/files/2014/11/discovery_medicine_no_fhtml?id=2|attachment_5
![Page 16: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/16.jpg)
Chimeric antigen receptor (CAR)
Antigen binding componentExpressed on outside of cell;This can be part of an antibody, or other moleculeusually binds HIV envelope on infected cellsHLA independent;
Signaling ComponentSends signal into the cellDirects the cell to kill HIV infected target
CD3ζ
BindsViral protein
enhance antigen recognition and cellular activation
![Page 17: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/17.jpg)
17
Engineered NK cells with “Chimeric antigen receptors” (CAR)
![Page 18: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/18.jpg)
Chimeric antigenreceptors(CARs)
o AdoptiveTcellstherapygeneticallymodifiedfortargetedcytotoxic
cellkillingholdsconsiderablepromiseandfortreatmentoftumorcells
orchronicviralinfections.
18
Targetedcell-killingstrategies
toachievedbyadoptivetransferofautologous CD8Tcellsgenetically
modifiedtoexpressaCARrecognizinganintactsurfaceantigen
preferentiallyexpressedonthesurfaceoftargetcells.
![Page 19: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/19.jpg)
3. Infuse the "boosted" T-cells into
the patient.
Overview: Adoptive T cell therapy
1. Isolation of TILs or tumor specific T-cells
from blood
2. Expand and activate T-cells ex vivo
Target therapy with Tumor specific T cells
Cancer: MelanomaAutologous tumor infiltrating lymphocytes (TILs); “Live drug”
AdvantagesHigh response rate (>50%), Long-term remission, Less toxic & gentler to the patient
Limitation: Extraction of TILs, Cell manufacturing
Possible alternateT cell Engineering (CAR-T cells)
Rosenberg SA & Dudley ME 2009 Current Opinion of Immunology
![Page 20: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/20.jpg)
Adoptive T cell therapy: CAR-T cells
Antigen specific domain
CAR-T cells (Chimeric antigen receptor-T cells0
T cells transduced with tumor-specific CARCAR: Single fusion molecule with antigen specificity plus signaling domainThree types of CAR: First/second/generations
Based on co-stimulatory receptorsCancer: Solid tumor & hematological malignancies
Maus M V et al. Blood 2014;123:2625-2635
“Live drug”
Tumor recognition independent of HLA
(no HLA typing needed)
Multiple anti-tumor immuno-modulators can be engineered
Target variety of antigens (protein,
carbohydrate, glycolipid)
Advantages of CAR T cells
![Page 21: Tumor Immunotherapy - NVInvi.ddc.moph.go.th/Download/eCTD/Module 1/8 Mar/6... · Clinical significance of CAR -T cells Target CAR Cancer Objective response CD19 CAR:CD28-CD3ζ Lymphoma](https://reader035.fdocuments.us/reader035/viewer/2022081409/6073ac6214688a7a546079e8/html5/thumbnails/21.jpg)
Clinical significance of CAR-T cells
Target CAR Cancer Objective response
CD19 CAR:CD28-CD3ζ Lymphoma and CLL
N=7: 1CR, 5 PR & 1SD
CAR:CD137-CD3ζ ALL 2CRCAR:CD28-CD3ζ ALL 5CR
CD20 CAR:CD137-CD28-CD3ζ
NHL N=3: 1PR, 2NED
CEA CAR-CD3ζ (1st gen) Colorectal & breast
N=7: minor responses in two patients
GD2 CAR-CD3ζ (1st gen) Neuroblastoma
N=19: 3CR
ERBB2 CAR:CD28-CD137-CD3ζ
Colorectalcancer
N=1, patient died
Kershaw et. al. 2013 Nature Reviews cancer